These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7700719)

  • 1. Clinical--molecular correlations in the skeletal dysplasias.
    Rimoin DL; Cohn DH; Eyre D
    Pediatr Radiol; 1994; 24(6):425-6. PubMed ID: 7700719
    [No Abstract]   [Full Text] [Related]  

  • 2. Abnormal type II collagen in the spondyloepiphyseal dysplasias.
    Murray LW; Rimoin DL
    Pathol Immunopathol Res; 1988; 7(1-2):99-103. PubMed ID: 3222214
    [No Abstract]   [Full Text] [Related]  

  • 3. Progress in medical genetics: map-based gene discovery and the molecular pathology of skeletal dysplasias.
    McKusick VA; Amberger JS; Francomano CA
    Am J Med Genet; 1996 May; 63(1):98-105. PubMed ID: 8723094
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone dysplasias due to abnormalities in type II collagen.
    Maroteaux P
    Rev Rhum Engl Ed; 1998 Apr; 65(4):221-4. PubMed ID: 9599789
    [No Abstract]   [Full Text] [Related]  

  • 5. Transgenic mouse models in studies of skeletal disorders.
    Jacenko O; Olsen BR
    J Rheumatol Suppl; 1995 Feb; 43():39-41. PubMed ID: 7752133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new concept of skeletal dysplasias.
    Tüysüz B
    Turk J Pediatr; 2004; 46(3):197-203. PubMed ID: 15503470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autosomal dominant and recessive osteochondrodysplasias associated with the COL11A2 locus.
    Vikkula M; Mariman EC; Lui VC; Zhidkova NI; Tiller GE; Goldring MB; van Beersum SE; de Waal Malefijt MC; van den Hoogen FH; Ropers HH
    Cell; 1995 Feb; 80(3):431-7. PubMed ID: 7859284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular defects in the chondrodysplasias.
    Rimoin DL
    Am J Med Genet; 1996 May; 63(1):106-10. PubMed ID: 8723095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kniest dysplasia is caused by dominant collagen II (COL2A1) mutations: parental somatic mosaicism manifesting as Stickler phenotype and mild spondyloepiphyseal dysplasia.
    Spranger J; Menger H; Mundlos S; Winterpacht A; Zabel B
    Pediatr Radiol; 1994; 24(6):431-5. PubMed ID: 7700721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of a type II collagen defect in spondyloepiphyseal dysplasia.
    Lee B; Vissing H; Ramirez F; Rogers D; Rimoin D
    Trans Assoc Am Physicians; 1989; 102():20-9. PubMed ID: 2638526
    [No Abstract]   [Full Text] [Related]  

  • 11. Type II collagen deficiency in achondrogenesis (Langer-Saldino).
    Eyre DR
    Pathol Immunopathol Res; 1988; 7(1-2):90-4. PubMed ID: 3222212
    [No Abstract]   [Full Text] [Related]  

  • 12. Mutations in three subdomains of the carboxy-terminal region of collagen type X account for most of the Schmid metaphyseal dysplasias.
    Bonaventure J; Chaminade F; Maroteaux P
    Hum Genet; 1995 Jul; 96(1):58-64. PubMed ID: 7607655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation of structurally defective type II collagen into cartilage matrix in kniest chondrodysplasia.
    Fernandes RJ; Wilkin DJ; Weis MA; Wilcox WR; Cohn DH; Rimoin DL; Eyre DR
    Arch Biochem Biophys; 1998 Jul; 355(2):282-90. PubMed ID: 9675039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the molecular defect in a family with spondyloepiphyseal dysplasia.
    Lee B; Vissing H; Ramirez F; Rogers D; Rimoin D
    Science; 1989 May; 244(4907):978-80. PubMed ID: 2543071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The type II collagenopathies: a spectrum of chondrodysplasias.
    Spranger J; Winterpacht A; Zabel B
    Eur J Pediatr; 1994 Feb; 153(2):56-65. PubMed ID: 8157027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel type X collagen gene mutation (G595R) associated with Schmid-type metaphyseal chondrodysplasia.
    Matsui Y; Yasui N; Kawabata H; Ozono K; Nakata K; Mizushima T; Tsumaki N; Kataoka E; Fujita Y; Ochi T
    J Hum Genet; 2000; 45(2):105-8. PubMed ID: 10721676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Osteochondrodysplasia determined genetically by a collagen type II gene mutation].
    Czarny-Ratajczak M; Rogala P; Wolnik-Brzozowska D; Latos-Bieleńska A
    Chir Narzadow Ruchu Ortop Pol; 2001; 66(1):79-86. PubMed ID: 11481990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent substitutions of arginine 789 by cysteine in pro-alpha 1 (II) collagen chains produce spondyloepiphyseal dysplasia congenita.
    Chan D; Rogers JF; Bateman JF; Cole WG
    J Rheumatol Suppl; 1995 Feb; 43():37-8. PubMed ID: 7752132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations affecting multiple functional domains of FGFR3 cause different skeletal dysplasias: a personal retrospective in honor of John Wasmuth.
    Cohn DH
    Ann N Y Acad Sci; 1996 Jun; 785():160-3. PubMed ID: 8702122
    [No Abstract]   [Full Text] [Related]  

  • 20. Spondylometaphyseal dysplasia in mice carrying a dominant negative mutation in a matrix protein specific for cartilage-to-bone transition.
    Jacenko O; LuValle PA; Olsen BR
    Nature; 1993 Sep; 365(6441):56-61. PubMed ID: 8361538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.